DeutschNewstral
Article
bizjournals.com on 2015-07-22 16:12
Peninsula biotech fails to find buyers for its IPO
Related news
- Heart biotech BioCardia hopes to raise up to $58M in IPObizjournals.com
- Biotech baker's dozen: Peninsula stalwart seeks Bay Area's 13th life sciences IPO this yearbizjournals.com
- Another Peninsula biotech seeks big IPO paydaybizjournals.com
- Potential Peninsula biotech IPO lands $46 millionbizjournals.com
- Cancer-fighting Peninsula biotech targets $100M IPObizjournals.com
- Venture-backed Md. biotech files for IPObizjournals.com
- Peninsula biotech returns with $92M offering after IPO postponementbizjournals.com
- Peninsula biotech hits top of IPO goals, raises $144Mbizjournals.com
- Peninsula biotech reveals phishing attack in IPO filingbizjournals.com
- What's next for this slow-moving Peninsula biotech IPO?bizjournals.com
- Peninsula biotech hikes IPO price targets by 28%bizjournals.com
- Aduro Biotech hits 'unicorn' exit with upsized $119M IPObizjournals.com
- Closely-watched Bay Area biotech CytomX prices below IPO rangebizjournals.com
- BioCardia to raise up to $62 million in IPObizjournals.com
- Biotech CytomX plans to raise up to $100M in IPObizjournals.com
- IPO-bound Bay Area biotech snags Big Pharma cancer dealbizjournals.com
- Berkeley cancer therapy startup Aduro Biotech seeks $86M in IPObizjournals.com